{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:39:09Z","timestamp":1780083549814,"version":"3.54.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NHS Fife","award":["ref 3416"],"award-info":[{"award-number":["ref 3416"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2022,1,15]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>National Institute for Health and Care Excellence (NICE) guidelines on intravenous fluid prescribing for adults in hospital, issued in 2013, advised less use of 0.9% sodium chloride than current practice, provided a logical system for prescribing and suggested further study of electrolyte abnormalities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To describe the steps taken to establish and monitor guideline introduction and to assess effects on clinical biochemistry results, in a general hospital setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used established principles of change to modify education, teaching, record keeping and audit throughout the hospital, changed the availability of intravenous fluid preparations in the wards and monitored the use of intravenous fluids. We anonymously linked local clinical chemistry records to nationally available patient records (NHS Scotland SMR01). We chose specified medical emergencies, and major emergency and elective general and orthopaedic surgery, where management would require intravenous fluids, for a two-phase cross-sectional study between 2007 and 2017, spanning the change in prescribing. Primary outcomes were abnormal bicarbonate, sodium, potassium and incidence of acute kidney injury (AKI), and secondary outcomes were mortality and length of stay.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over the study period, sodium chloride 0.9% use decreased by 75%, and overall intravenous fluid use decreased from 0.65 to 0.40\u2009L\/occupied bed day. The incidence of acidosis decreased from 7.4% to 4.8% of all admissions (difference \u22122.7%, 95%\u2009CI \u22122.1 to \u22123.0). No important changes in other electrolytes were noted; in particular, plasma sodium values showed no adverse effects. Stage 1 AKI increased from 6.7% to 9.0% (difference 2.3%, 95%\u2009CI 1.6 to 3.0), but other causes for this cannot be excluded. Mortality and length of stay showed no adverse effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions and implications<\/jats:title>\n                  <jats:p>Effective implementation of the guidelines required substantial time, effort and resource. NICE suggestions of fluid types for maintenance appear appropriate, but prescribed volumes continue to require careful clinical judgement.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjoq-2021-001636","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T11:47:15Z","timestamp":1643888835000},"page":"e001636","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Introducing NICE guidelines for intravenous fluid therapy into a district general hospital"],"prefix":"10.1136","volume":"11","author":[{"given":"Marcia","family":"McDougall","sequence":"first","affiliation":[{"name":"Department of Anaesthesia, Victoria Hospital, Kirkcaldy, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4191-4880","authenticated-orcid":false,"given":"Bruce","family":"Guthrie","sequence":"additional","affiliation":[{"name":"University of Edinburgh, Community Health Sciences, Edinburgh, Midlothian, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Doyle","sequence":"additional","affiliation":[{"name":"Renal Unit, Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Timmins","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Victoria Hospital, Kirkcaldy, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Bateson","sequence":"additional","affiliation":[{"name":"Institute of Healthcare Policy and Practice, University of the West of Scotland, Blantyre, South Lanarkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ridley","sequence":"additional","affiliation":[{"name":"Anaesthesia, Victoria Hospital, Kirkcaldy, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7038-1887","authenticated-orcid":false,"given":"Gordon","family":"Drummond","sequence":"additional","affiliation":[{"name":"Edinburgh Medical School, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thenmalar","family":"Vadiveloo","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, School of Medical Sciences, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"2025083113002525000_11.1.e001636.1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6920-14-35"},{"key":"2025083113002525000_11.1.e001636.2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/S40037-017-0386-5","article-title":"Learning to prescribe intravenous fluids: A\u00a0scoping review","volume":"6","author":"McCrory","year":"2017","journal-title":"Perspect Med Educ"},{"key":"2025083113002525000_11.1.e001636.3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13741-015-0025-9","article-title":"Perioperative intravenous fluid prescribing: a multi-centre audit","volume":"4","author":"Harris","year":"2015","journal-title":"Perioper Med"},{"key":"2025083113002525000_11.1.e001636.4","doi-asserted-by":"publisher","DOI":"10.1054\/clnu.2000.0154"},{"key":"2025083113002525000_11.1.e001636.5","doi-asserted-by":"publisher","DOI":"10.1046\/j.0966-0429.2001.00296.x"},{"key":"2025083113002525000_11.1.e001636.6","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.7-5-482"},{"key":"2025083113002525000_11.1.e001636.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.03.009"},{"key":"2025083113002525000_11.1.e001636.8","doi-asserted-by":"publisher","DOI":"10.1258\/cr.2009.090005"},{"key":"2025083113002525000_11.1.e001636.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f801"},{"key":"2025083113002525000_11.1.e001636.10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00134-019-05772-1","article-title":"154 compared to 54\u00a0mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized controlled double-blind trial","volume":"45","author":"Van Regenmortel","year":"2019","journal-title":"Intensive Care Med"},{"key":"2025083113002525000_11.1.e001636.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1412877"},{"key":"2025083113002525000_11.1.e001636.12","first-page":"13","article-title":"British consensus guidelines on intravenous fluid therapy for adult surgical patients (GIFTASUP): Cassandra's view","volume":"64","author":"Soni","year":"2009","journal-title":"Anaesthesia"},{"key":"2025083113002525000_11.1.e001636.13","unstructured":"National Institute for Health and Care Excellence . Intravenous fluid therapy in adults in hospital Clinical guideline [CG174], 2013."},{"key":"2025083113002525000_11.1.e001636.14","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12644"},{"key":"2025083113002525000_11.1.e001636.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885"},{"key":"2025083113002525000_11.1.e001636.16","doi-asserted-by":"crossref","unstructured":"Kotter JP . Leading change. Boston, Mass: Harvard Business School Press, 2012.","DOI":"10.15358\/9783800646159"},{"key":"2025083113002525000_11.1.e001636.17","unstructured":"National Confidential enquiry into patient outcome and death. extremes of age report, 1999. Available: https:\/\/www.ncepod.org.uk\/1999ea.html"},{"key":"2025083113002525000_11.1.e001636.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"2025083113002525000_11.1.e001636.19","unstructured":"ISD Scotland . General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01). Available: https:\/\/www.ndc.scot.nhs.uk\/National-Datasets\/data.asp?ID=1&SubID=5 [Accessed 17 Dec 2020]."},{"key":"2025083113002525000_11.1.e001636.20","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.1"},{"key":"2025083113002525000_11.1.e001636.21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"2025083113002525000_11.1.e001636.22","unstructured":"Lowry R . VassarStats. Available: http:\/\/www.vassarstats.net\/ [Accessed 11 Apr 2020]."},{"key":"2025083113002525000_11.1.e001636.23","unstructured":"Zar JH . Biostatistical analysis. 3rd ed. London: Prentice Hall International, 1996."},{"key":"2025083113002525000_11.1.e001636.24","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0433"},{"key":"2025083113002525000_11.1.e001636.25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4997\/jrcpe.2020.224","article-title":"Improving intravenous fluid prescribing","volume":"50","author":"Mathur","year":"2020","journal-title":"J R Coll Physicians Edinb"},{"key":"2025083113002525000_11.1.e001636.26","unstructured":"Public Health Scotland . Hospital medicines utilisation database. Available: https:\/\/www.isdscotland.org\/Health-Topics\/Prescribing-and-Medicines\/Prescribing-Datamarts\/#hmud [Accessed 21 Jun 2020]."},{"key":"2025083113002525000_11.1.e001636.27","unstructured":"NHS National Services Scotland . Assessment of SMR01 data Scotland 2014-2015. Available: https:\/\/beta.isdscotland.org\/products-and-services\/data-quality-assurance\/dqa-assessments\/ [Accessed 17 Dec 2020]."},{"key":"2025083113002525000_11.1.e001636.28","unstructured":"McDougall M , Ridley E . Junior doctors\u2019 attitudes to fluid prescribing in NHS Fife. Scott Med J 2021."},{"key":"2025083113002525000_11.1.e001636.29","article-title":"Fluid prescribing and administration: are we following NHS Fife IV fluid guidance?","volume":"66","author":"Ridley","year":"2021","journal-title":"Scott Med J"},{"key":"2025083113002525000_11.1.e001636.30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1017\/S0029665110003824","article-title":"Improving peri-operative fluid management in a large teaching hospital: pragmatic studies on the effects of changing practice","volume":"69","author":"De Silva","year":"2010","journal-title":"Proc Nutr Soc"},{"key":"2025083113002525000_11.1.e001636.31","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31825074f5"},{"key":"2025083113002525000_11.1.e001636.32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00134-014-3593-0","article-title":"Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis","volume":"41","author":"Yunos","year":"2015","journal-title":"Intensive Care Med"},{"key":"2025083113002525000_11.1.e001636.33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SLA.0000000000001402","article-title":"Perioperative fluid utilization variability and association with outcomes: considerations for enhanced recovery efforts in sample us surgical populations","volume":"263","author":"Thacker","year":"2016","journal-title":"Ann Surg"},{"key":"2025083113002525000_11.1.e001636.34","unstructured":"The Scottish Arthroplasty Project Annual Report, 2018. Available: https:\/\/www.arthro.scot.nhs.uk\/docs\/2018\/2018-08-14-SAP-Annual-Report.pdf [Accessed 9 May 2020]."},{"key":"2025083113002525000_11.1.e001636.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-012-1619-z"},{"key":"2025083113002525000_11.1.e001636.36","unstructured":"The Scottish arthroplasty project report, 2019. Available: https:\/\/www.arthro.scot.nhs.uk\/Reports\/Visualisation.html [Accessed 9 May 2020]."},{"key":"2025083113002525000_11.1.e001636.37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0000000000002220","article-title":"Effects of intraoperative fluid management on postoperative outcomes: a hospital registry study","volume":"267","author":"Shin","year":"2018","journal-title":"Ann Surg"},{"key":"2025083113002525000_11.1.e001636.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801601"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2021-001636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T20:00:34Z","timestamp":1756670434000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2021-001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2,3]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bmjoq-2021-001636"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2021-001636","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}